Arkansas Legal Resource Navigator

21 U.S.C. § 376 — Examination of sea food on request of

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 376 — Examination of sea food on request of

Page 505 TITLE 21—FOOD AND DRUGS § 376 ‘‘(B) provides for standardized methods for commu- nications described in such paragraphs; ‘‘(C) establishes, with respect to inspections of both domestic and foreign device establishments (as re- ferred to in section 510(h)(2) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360(h)(2)], as amended by subsection (a) [of section 701 of Pub. L. 115–52]), a standard timeframe for such inspections— ‘‘(i) that occurs over consecutive days; and ‘‘(ii) to which each investigator conducting such an inspection shall adhere unless the investigator identifies to the establishment involved a reason that more time is needed to conduct such investiga- tion; and ‘‘(D) identifies practices for investigators and de- vice establishments to facilitate the continuity of in- spections of such establishments. ‘‘(2) FINAL GUIDANCE.—Not later than 1 year after pro- viding notice and opportunity for public comment on the draft guidance issued under paragraph (1), the Sec- retary of Health and Human Services shall issue final guidance to implement subsection (h) of section 704 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 374), as added by subsection (a).’’ INSPECTIONS Pub. L. 115–52, title VIII, § 806, Aug. 18, 2017, 131 Stat. 1073, provided that: ‘‘Within 6 months of the date of enactment of this Act [Aug. 18, 2017], the Secretary of Health and Human Services shall develop and implement a protocol for ex- pediting review of timely responses to reports of obser- vations from an inspection under section 704 of the Fed- eral Food, Drug, and Cosmetic Act (21 U.S.C. 374). Such protocol shall— ‘‘(1) apply to responses to such reports pertaining to applications submitted under section 505 of the Federal Food, Drug, and Cosme

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 376

Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 7f6d2de3279e7cf8fbe061fbd8047933269787c8f26ea21d9fb8d7ee2a96cf25. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:usc2024-8f64b8d61ffb660f0e101b23
Source file: Laws/federal/codes/united-states-code-2024/title-21/section-376-examination-of-sea-food-on-request-of--56d2ed91ed.md
Pages: Not recorded – Not recorded
Passage SHA-256: 5142a93ac1f45dae0680c0b98fb1d5c0431b7ee1be63250a4fcdcbb7d3187671

Source location: USCODE-2024-title21-chap9-subchapVII-partA-sec376.pdf

Stored source content

Page 505 TITLE 21—FOOD AND DRUGS § 376 ‘‘(B) provides for standardized methods for commu- nications described in such paragraphs; ‘‘(C) establishes, with respect to inspections of both domestic and foreign device establishments (as re- ferred to in section 510(h)(2) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360(h)(2)], as amended by subsection (a) [of section 701 of Pub. L. 115–52]), a standard timeframe for such inspections— ‘‘(i) that occurs over consecutive days; and ‘‘(ii) to which each investigator conducting such an inspection shall adhere unless the investigator identifies to the establishment involved a reason that more time is needed to conduct such investiga- tion; and ‘‘(D) identifies practices for investigators and de- vice establishments to facilitate the continuity of in- spections of such establishments. ‘‘(2) FINAL GUIDANCE.—Not later than 1 year after pro- viding notice and opportunity for public comment on the draft guidance issued under paragraph (1), the Sec- retary of Health and Human Services shall issue final guidance to implement subsection (h) of section 704 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 374), as added by subsection (a).’’ INSPECTIONS Pub. L. 115–52, title VIII, § 806, Aug. 18, 2017, 131 Stat. 1073, provided that: ‘‘Within 6 months of the date of enactment of this Act [Aug. 18, 2017], the Secretary of Health and Human Services shall develop and implement a protocol for ex- pediting review of timely responses to reports of obser- vations from an inspection under section 704 of the Fed- eral Food, Drug, and Cosmetic Act (21 U.S.C. 374). Such protocol shall— ‘‘(1) apply to responses to such reports pertaining to applications submitted under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355)— ‘‘(A) for which the approval is dependent upon re- mediation of conditions identified in the report; ‘‘(B) for which concerns related to observations from an inspection under such section 704 are the only barrier to approval; and ‘‘(C) where the drug that is the subject of the ap- plication is a drug— ‘‘(i) for which there are not more than 3 other approved applications under section 505(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)) that reference the same listed drug and for which there are less than 6 abbreviated new drug applications tentatively approved; or ‘‘(ii) that is included on the list under section 506E of such Act (21 U.S.C. 356e); ‘‘(2) address expedited re-inspection of facilities, as appropriate; and ‘‘(3) establish a 6-month timeline for completion of review of such responses to such reports.’’ AUTHORITY OF SECRETARY PRIOR TO OCTOBER 10, 1962 Pub. L. 87–781, title II, § 201(d), Oct. 10, 1962, 76 Stat. 793, provided that: ‘‘Nothing in the amendments made by subsections (a) and (b) of this section [amending this section] shall be construed to negate or derogate from any authority of the Secretary existing prior to the en- actment of this Act [Oct. 10, 1962].’’ Executive Documents TRANSFER OF FUNCTIONS For transfer of functions of Federal Security Admin- istrator to Secretary of Health, Education, and Welfare [now Health and Human Services], and of Food and Drug Administration in the Department of Agriculture to Federal Security Agency, see notes set out under section 321 of this title. § 374a. Inspections relating to food allergens The Secretary of Health and Human Services shall conduct inspections consistent with the authority under section 374 of this title of facili- ties in which foods are manufactured, processed, packed, or held— (1) to ensure that the entities operating the facilities comply with practices to reduce or eliminate cross-contact of a food with residues of major food allergens that are not inten- tional ingredients of the food; and (2) to ensure that major food allergens are properly labeled on foods. (Pub. L. 108–282, title II, § 205, Aug. 2, 2004, 118 Stat. 909.) Editorial Notes CODIFICATION Section was enacted as a part of the Food Allergen Labeling and Consumer Protection Act of 2004, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter. § 375. Publicity (a) Reports The Secretary shall cause to be published from time to time reports summarizing all judg- ments, decrees, and court orders which have been rendered under this chapter, including the nature of the charge and the disposition thereof. (b) Information regarding certain goods The Secretary may also cause to be dissemi- nated information regarding food, drugs, de- vices, tobacco products, or cosmetics in situa- tions involving, in the opinion of the Secretary, imminent danger to health or gross deception of the consumer. Nothing in this section shall be construed to prohibit the Secretary from col- lecting, reporting, and illustrating the results of the investigations of the Department. (June 25, 1938, ch. 675, § 705, 52 Stat. 1057; Pub. L. 111–31, div. A, title I, § 103(j), June 22, 2009, 123 Stat. 1837.) Editorial Notes AMENDMENTS 2009—Subsec. (b). Pub. L. 111–31 inserted ‘‘tobacco products,’’ after ‘‘devices,’’. Executive Documents TRANSFER OF FUNCTIONS For transfer of functions of Federal Security Admin- istrator to Secretary of Health, Education, and Welfare [now Health and Human Services], and of Food and Drug Administration in the Department of Agriculture to Federal Security Agency, see notes set out under section 321 of this title. § 376. Examination of sea food on request of packer; marking food with results; fees; pen- alties The Secretary, upon application of any packer of any sea food for shipment or sale within the jurisdiction of this chapter, may, at his discre- tion, designate inspectors to examine and in- spect such food and the production, packing, and labeling thereof. If on such examination and in- spection compliance is found with the provisions of this chapter and regulations promulgated thereunder, the applicant shall be authorized or Page 506 TITLE 21—FOOD AND DRUGS § 377 required to mark the food as provided by regula- tion to show such compliance. Services under this section shall be rendered only upon pay- ment by the applicant of fees fixed by regulation in such amounts as may be necessary to provide, equip, and maintain an adequate and efficient inspection service. Receipts from such fees shall be covered into the Treasury and shall be avail- able to the Secretary for expenditures incurred in carrying out the purposes of this section, in- cluding expenditures for salaries of additional inspectors when necessary to supplement the number of inspectors for whose salaries Con- gress has appropriated. The Secretary is author- ized to promulgate regulations governing the sanitary and other conditions under which the service herein provided shall be granted and maintained, and for otherwise carrying out the purposes of this section. Any person who forges, counterfeits, simulates, or falsely represents, or without proper authority uses any mark, stamp, tag, label, or other identification devices au- thorized or required by the provisions of this section or regulations thereunder, shall be guilty of a misdemeanor, and shall on convic- tion thereof be subject to imprisonment for not more than one year or a fine of not less than $1,000 nor more than $5,000, or both such impris- onment and fine. (June 25, 1938, ch. 675, § 706, formerly § 702A, for- merly June 30, 1906, ch. 3915, § 10A, as added June 22, 1934, ch. 712, 48 Stat. 1204; amended Aug. 27, 1935, ch. 739, 49 Stat. 871; June 25, 1938, ch. 675, § 1002(a), formerly § 902(a), 52 Stat. 1059, renum- bered § 1002(a), Pub. L. 111–31, div. A, title I, § 101(b)(2), June 22, 2009, 123 Stat. 1784; renum- bered § 702A of act June 25, 1938, July 12, 1943, ch. 221, title II, 57 Stat. 500; Pub. L. 102–300, § 6(b)(2), June 16, 1992, 106 Stat. 240; renumbered § 706, Pub. L. 102–571, title I, § 106(3), Oct. 29, 1992, 106 Stat. 4498; Pub. L. 103–80, § 3(dd)(2), Aug. 13, 1993, 107 Stat. 779.) Editorial Notes CODIFICATION Section was formerly classified to section 372a of this title prior to renumbering by Pub. L. 102–571. Section, which formerly was not a part of the Federal Food, Drug, and Cosmetic Act, originally was classified to section 14a of this title. Section 1002(a) of act June 25, 1938, set out as an Effective Date note under section 301 of this title, provided that the section should re- main in force and effect and be applicable to the provi- sions of this chapter. Act July 12, 1943, renumbered this section as 702A of the Federal Food, Drug, and Cos- metic Act. PRIOR PROVISIONS A prior section 376, act June 25, 1938, ch. 675, § 706, 52 Stat. 1058, as amended, which related to listing and cer- tification of color additives for foods, drugs, devices, and cosmetics, was renumbered section 721 of act June 25, 1938, by Pub. L. 102–571, title I, § 106(4), Oct. 29, 1992, 106 Stat. 4498, and transferred to section 379e of this title. AMENDMENTS 1993—Pub. L. 103–80 struck out ‘‘of Agriculture’’ after ‘‘Secretary’’ in two places. 1992—Pub. L. 102–300, which directed the amendment of the section by striking out ‘‘of Health, Education, and Welfare’’ wherever appearing, could not be exe- cuted because such words did not appear in the original statutory text. See 1993 Amendment note above and Transfer of Functions note below. Statutory Notes and Related Subsidiaries TRANSFER OF FUNCTIONS Secretary and Department of Health, Education, and Welfare redesignated Secretary and Department of Health and Human Services by Pub. L. 96–88, title V, § 509(b), Oct. 17, 1979, 93 Stat. 695, which is classified to section 3508(b) of Title 20, Education. Executive Documents TRANSFER OF FUNCTIONS For transfer of functions of Federal Security Admin- istrator to Secretary of Health, Education, and Welfare [now Health and Human Services], and of Food and Drug Administration in the Department of Agriculture to Federal Security Agency, see notes set out under section 321 of this title. § 377. Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests The Secretary, in carrying into effect the pro- visions of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], is authorized on and after July 12, 1943, to cooperate with associa- tions and scientific societies in the revision of the United States Pharmacopoeia and in the de- velopment of methods of analysis and mechan- ical and physical tests necessary to carry out the work of the Food and Drug Administration. (July 12, 1943, ch. 221, title II, 57 Stat. 500; 1953 Reorg. Plan No. 1, § 5, eff. Apr. 11, 1953, 18 F.R. 2053, 67 Stat. 631.) Editorial Notes REFERENCES IN TEXT The Federal Food, Drug, and Cosmetic Act, referred to in text, is act June 25, 1938, ch. 675, 52 Stat. 1040, which is classified generally to this chapter. For com- plete classification of this Act to the Code, see section 301 of this title and Tables. CODIFICATION Section was enacted as part of the Labor-Federal Se- curity Appropriation Act, 1944, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter. Executive Documents TRANSFER OF FUNCTIONS For transfer of functions of Federal Security Admin- istrator to Secretary of Health, Education, and Welfare [now Health and Human Services], and of Food and Drug Administration in the Department of Agriculture to Federal Security Agency, see notes set out under section 321 of this title. § 378. Advertising of foods (a) Determination of misbranding; notification of Federal Trade Commission by Secretary; contents (1) Except as provided in subsection (c), before the Secretary may initiate any action under subchapter III— (A) with respect to any food which the Sec- retary determines is misbranded under section

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 301 — Short title

This chapter may be cited as the Federal Food, Drug, and Cosmetic Act.

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 301

Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 301. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 301 — Short title

Page 30 TITLE 21—FOOD AND DRUGS § 301 Sec. 398. Notices to States regarding imported food. 399. Grants to enhance food safety. 399a. Office of the Chief Scientist. 399b. Office of Women’s Health. 399c. Improving the training of State, local, terri- torial, and tribal food safety officials. 399d. Employee protections. 399e. Nanotechnology. 399f. Ensuring adequate information regarding pharmaceuticals for all populations, par- ticularly underrepresented subpopulations, including racial subgroups. 399g. Food and Drug Administration Intercenter Institutes. 399h. National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufac- turing. 399i. Food and Drug Administration Working Cap- ital Fund. SUBCHAPTER I—SHORT TITLE § 301. Short title This chapter may be cited as the Federal Food, Drug, and Cosmetic Act. (June 25, 1938, ch. 675, § 1, 52 Stat. 1040.) Statutory Notes and Related Subsidiaries EFFECTIVE DATE; POSTPONEMENT IN CERTAIN CASES Act June 23, 1939, ch. 242, §§ 1, 2, 53 Stat. 853, 854, pro- vided that: ‘‘[SEC. 1] (a) The effective date of the following provi- sions of the Federal Food, Drug, and Cosmetic Act is hereby postponed until January 1, 1940: Sections 402(c) [342(c) of this title]; 403(e)(1) [343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g) to (k) of this title]; 501(a), (4) [351(a)(4) of this title]; 502(b), (d), (e), (f), (g), and (h) [352(b), (d) to (h) of this title]; 601(e) [361(e) of this title]; and 602(b) [362(b) of this title]. ‘‘(b) The Secretary of Agriculture shall promulgate regulations further postponing to July 1, 1940[,] the ef- fective date of the provisions of sections 403(e)(1) [343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g) to (k)]; 502(b), (d), (

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 301

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 301. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 355 — New drugs

**(a) Necessity of effective approval of application** No person shall introduce or deliver for introduction into interstate commerce any new drug, unless an approval of an application filed pursuant to subsection (b) or (j) is effective with respect to such drug. **(b) Filing application; contents** (1) (A) Any person may file with the Secretary an application with respect to any drug subject to the provisions of subsection (a). Such persons shall submit to the Secretary as part of the application— (i) full reports of investigations which have been made to show whether such drug is safe for use and whether such drug is effective in use; (ii) a full list of the articles used as components of such drug; (iii) a full statement of the composition of such drug; (iv) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug; (v) such samples of such drug and of the articles used as components thereof as the Secretary may require; (vi) specimens of the labeling proposed to be used for such drug; (vii) any assessments required under [section 355c of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section355c&num=0&edition=prelim); and (viii) the patent number and expiration date of each patent for which a claim of patent infringement could reasonably be asserted if a person not licensed by the owner of the patent engaged in the manufacture, use, or sale of the drug, and that— (I) claims the drug for which the applicant submitted the application and is a drug substance (active ingredient) patent or a drug product (formulation or composition) patent; or (II) claims a method of using such drug for which approv

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 355

Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 355. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 355 — New drugs

Page 186 TITLE 21—FOOD AND DRUGS § 355 § 355. New drugs (a) Necessity of effective approval of application No person shall introduce or deliver for intro- duction into interstate commerce any new drug, unless an approval of an application filed pursu- ant to subsection (b) or (j) is effective with re- spect to such drug. (b) Filing application; contents (1)(A) Any person may file with the Secretary an application with respect to any drug subject to the provisions of subsection (a). Such persons shall submit to the Secretary as part of the ap- plication— (i) full reports of investigations which have been made to show whether such drug is safe for use and whether such drug is effective in use; (ii) a full list of the articles used as compo- nents of such drug; (iii) a full statement of the composition of such drug; (iv) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug; (v) such samples of such drug and of the arti- cles used as components thereof as the Sec- retary may require; (vi) specimens of the labeling proposed to be used for such drug; (vii) any assessments required under section 355c of this title; and (viii) the patent number and expiration date of each patent for which a claim of patent in- fringement could reasonably be asserted if a person not licensed by the owner of the patent engaged in the manufacture, use, or sale of the drug, and that— (I) claims the drug for which the applicant submitted the application and is a drug sub- stance (active ingredient) patent or a drug product (formulation or composition) pat- ent; or (II) claims a method of using such drug for which approval is sought or has been granted in the application. (B) If an a

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 355

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 355. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 356e — Drug shortage list

**(a) Establishment** The Secretary shall maintain an up-to-date list of drugs that are determined by the Secretary to be in shortage in the United States. **(b) Contents** For each drug on such list, the Secretary shall include the following information: (1) The name of the drug in shortage, including the National Drug Code number for such drug. (2) The name of each manufacturer of such drug. (3) The reason for the shortage, as determined by the Secretary, selecting from the following categories: (A) Requirements related to complying with good manufacturing practices. (B) Regulatory delay. (C) Shortage of an active ingredient. (D) Shortage of an inactive ingredient component. (E) Discontinuance of the manufacture of the drug. (F) Delay in shipping of the drug. (G) Demand increase for the drug. (4) The estimated duration of the shortage as determined by the Secretary. **(c) Public availability** (1) **In general** — Subject to paragraphs (2) and (3), the Secretary shall make the information in such list publicly available. (2) **Trade secrets and confidential information** — Nothing in this section alters or amends [section 1905 of title 18](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title18-section1905&num=0&edition=prelim) or [section 552(b)(4) of title 5](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title5-section552/b/4&num=0&edition=prelim). (3) **Public health exception** — The Secretary may choose not to make information collected under this section publicly available under paragraph (1) or [section 356c(c) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section356c/c&num=0&edition=prelim) if the Secretary determines that disclosure of such information would advers

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 356e

Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 356e. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 356e — Drug shortage list

Page 288 TITLE 21—FOOD AND DRUGS § 356e (1) be subject to judicial review; or (2) be construed to establish a defense to an enforcement action by the Secretary. (f) Temporary sunset Subsection (a) shall cease to be effective on the date that is 5 years after July 9, 2012. Sub- sections (b), (c), and (e) shall not be in effect during the period beginning 5 years after July 9, 2012, and ending on December 29, 2022. Sub- sections (b), (c), and (e) shall be in effect begin- ning on December 29, 2022. (g) Coordination The Secretary shall ensure timely and effec- tive internal coordination and alignment among the field investigators of the Food and Drug Ad- ministration and the staff of the Center for Drug Evaluation and Research’s Office of Compliance and Drug Shortage Program regarding— (1) the reviews of reports shared pursuant to section 374(b)(2) of this title; and (2) any feedback or corrective or preventive actions in response to such reports. (June 25, 1938, ch. 675, § 506D, as added Pub. L. 112–144, title X, § 1003, July 9, 2012, 126 Stat. 1103; amended Pub. L. 117–328, div. FF, title III, § 3616(a), Dec. 29, 2022, 136 Stat. 5874.) Editorial Notes AMENDMENTS 2022—Subsec. (f). Pub. L. 117–328, § 3616(a)(2), amended subsec. (f) generally. Prior to amendment, text read as follows: ‘‘Subsections (a), (b), (c), and (e) shall cease to be effective on the date that is 5 years after July 9, 2012.’’ Subsec. (g). Pub. L. 117–328, § 3616(a)(1), added subsec. (g). § 356e. Drug shortage list (a) Establishment The Secretary shall maintain an up-to-date list of drugs that are determined by the Sec- retary to be in shortage in the United States. (b) Contents For each drug on such list, the Secretary shall include the following information: (1) The

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 356e

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 356e. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 360 — Registration of producers of drugs or devices

**(a) Definitions** As used in this section— (1) the term “manufacture, preparation, propagation, compounding, or processing” shall include repackaging or otherwise changing the container, wrapper, or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer or user; and (2) the term “name” shall include in the case of a partnership the name of each partner and, in the case of a corporation, the name of each corporate officer and director, and the State of incorporation. **(b) Annual registration** (1) During the period beginning on October 1 and ending on December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, preparation, propagation, compounding, or processing of a drug or drugs shall register with the Secretary the name of such person, places of business of such person, all such establishments, the unique facility identifier of each such establishment, and a point of contact e-mail address. (2) During the period beginning on October 1 and ending on December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, preparation, propagation, compounding, or processing of a device or devices shall register with the Secretary his name, places of business, and all such establishments. (3) The Secretary shall specify the unique facility identifier system that shall be used by registrants under paragraph (1). The requirement to include a unique facility identifier in a registration under paragraph (1) shall not apply until the date that the identifier system is specified by the Secretary under the pr

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 360

Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 360. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 360 — Registration of producers of drugs or de-

Page 301 TITLE 21—FOOD AND DRUGS § 360 1 So in original. sections 358 to 360 of this title, amended sections 351 to 353, 355, and 357 of this title, and enacted provisions set out as notes under sections 352, 355, 358, and 360 of this title. The Drug Amendments of 1962, referred to in text, is Pub. L. 87–781, Oct. 10, 1962, 76 Stat. 780, as amended. For complete classification of this Act to the Code, see Short Title of 1962 Amendment note set out under sec- tion 301 of this title and Tables. § 360. Registration of producers of drugs or de- vices (a) Definitions As used in this section— (1) the term ‘‘manufacture, preparation, propagation, compounding, or processing’’ shall include repackaging or otherwise chang- ing the container, wrapper, or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the per- son who makes final delivery or sale to the ul- timate consumer or user; and (2) the term ‘‘name’’ shall include in the case of a partnership the name of each partner and, in the case of a corporation, the name of each corporate officer and director, and the State of incorporation. (b) Annual registration (1) During the period beginning on October 1 and ending on December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, prepa- ration, propagation, compounding, or processing of a drug or drugs shall register with the Sec- retary the name of such person, places of busi- ness of such person, all such establishments, the unique facility identifier of each such establish- ment, and a point of contact e-mail address. (2) During the period beginning on October 1 and ending on December 31 of ea

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 360

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 360. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 374 — Inspection

**(a) Right of agents to enter; scope of inspection; notice; promptness; exclusions** (1) For purposes of enforcement of this chapter, officers or employees duly designated by the Secretary, upon presenting appropriate credentials and a written notice to the owner, operator, or agent in charge, are authorized (A) to enter, at reasonable times, any factory, warehouse, or establishment in which food, drugs, devices, tobacco products, or cosmetics are manufactured, processed, packed, or held, for introduction into interstate commerce or after such introduction, or to enter any vehicle being used to transport or hold such food, drugs, devices, tobacco products, or cosmetics in interstate commerce; and (B) to inspect, at reasonable times and within reasonable limits and in a reasonable manner, such factory, warehouse, establishment, or vehicle and all pertinent equipment, finished and unfinished materials, containers, and labeling therein. In the case of any person (excluding farms and restaurants) who manufactures, processes, packs, transports, distributes, holds, or imports foods, the inspection shall extend to all records and other information described in [section 350c of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c&num=0&edition=prelim), when the standard for records inspection under paragraph (1) or (2) of [section 350c(a) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c/a&num=0&edition=prelim) applies, subject to the limitations established in [section 350c(d) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c/d&num=0&edition=prelim). In the case of a facility (as defined in [section 364 of this title](https://uscode.house.gov/vi

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 374

Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 374. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 374 — Inspection

Page 495 TITLE 21—FOOD AND DRUGS § 374 kind of food, drug, device, tobacco product, or cosmetic to which such request relates, except that evidence obtained under this section, or any evidence which is directly or indirectly de- rived from such evidence, shall not be used in a criminal prosecution of the person from whom obtained, and except that carriers shall not be subject to the other provisions of this chapter by reason of their receipt, carriage, holding, or delivery of food, drugs, devices, tobacco prod- ucts, or cosmetics in the usual course of busi- ness as carriers, except as provided in subsection (b). (b) Food transportation records A shipper, carrier by motor vehicle or rail ve- hicle, receiver, or other person subject to sec- tion 350e of this title shall, on request of an offi- cer or employee designated by the Secretary, permit the officer or employee, at reasonable times, to have access to and to copy all records that the Secretary requires to be kept under section 350e(c)(1)(E) of this title. (June 25, 1938, ch. 675, § 703, 52 Stat. 1057; Pub. L. 91–452, title II, § 230, Oct. 15, 1970, 84 Stat. 930; Pub. L. 103–80, § 3(z), Aug. 13, 1993, 107 Stat. 778; Pub. L. 109–59, title VII, § 7202(c), Aug. 10, 2005, 119 Stat. 1913; Pub. L. 111–31, div. A, title I, § 103(h), June 22, 2009, 123 Stat. 1837.) Editorial Notes AMENDMENTS 2009—Subsec. (a). Pub. L. 111–31 inserted ‘‘tobacco product,’’ after ‘‘device,’’ in two places and ‘‘tobacco products,’’ after ‘‘devices,’’ in two places. 2005—Pub. L. 109–59 struck out ‘‘of interstate ship- ment’’ after ‘‘Records’’ in section catchline, designated existing provisions as subsec. (a), inserted subsec. head- ing, substituted ‘‘carriers, except as provided in sub- section (b)’’ for ‘‘carriers’’ b

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 374

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 374. This identifies an authority to review, not proof of applicability.